最新更新 :
19/11/2024
研究小組 - Faculty of pharmacy, State university of Utrecht   PDF  
荷兰
大學
Faculty of pharmacy, State university of Utrecht
Utrecht
引用文献   引用文献   (15)  
1
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. (a.mehta@nki.nl)
Int J Pharm - 2015 - ; 479 : 23-27.
2
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R. ()
J Parenter Sci Technol - 1993 - ; 47: 166-171.
3
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M. ()
Int J Pharm - 1993 - ; 99: 73-78.
4
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM. ()
J Parenter Sci Technol - 1992 - ; 46: 111-116.
5
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1991 - ; 45: 108-112.
6
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM. ()
Ann Pharmacotherapy - 1990 - ; 24: 1056-1058.
7
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1990 - ; 44: 332-335.
8
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
Beijnen JH, Vendrig DEMM, Underberg WJM. ()
J Parenter Sci Technol - 1989 - ; 43: 84-87.
9
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM. ()
Int J Pharm - 1988 - ; 43: 131-138.
10
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH. ()
Pharm Weekbl [Sci] - 1988 - ; 10: 213-216.
11
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM. ()
Am J Hosp Pharm - 1986 - ; 43: 3022-3027.
12
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM. ()
Int J Pharm - 1986 - ; 32: 123-131.
14
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans . ()
Pharm Weekbl [Sci] - 1986 - ; 8: 286-288.
15
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM. ()
J Parenter Sci Technol - 1985 - ; 39: 220-222.

药品清单   分子研究   (16)  
抗癌藥物 注射液 Cyclophosphamide
抗癌藥物 注射液 Daunorubicin hydrochloride
细胞保护剂 注射液 Dexrazoxane hydrochloride
抗癌藥物 注射液 Doxorubicin hydrochloride
抗癌藥物 注射液 Epirubicin hydrochloride
抗癌藥物 注射液 Etoposide
抗癌藥物 注射液 Idarubicin hydrochloride
降血糖药 注射液 Insulin
抗癌藥物 注射液 Mitomycin
抗癌藥物 注射液 Nimustine
抗癌藥物 注射液 Oxaliplatin
抗寄生虫药 注射液 Suramin
抗癌藥物 注射液 Teniposide
抗癌藥物 注射液 Vinblastine sulfate
抗癌藥物 注射液 Vincristine sulfate
抗癌藥物 注射液 Vindesine sulfate

  Mentions Légales